CoChat

Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

High-mobility group box 1 (HMGB1) functions as a proinflammatory cytokine and is one of the most intriguing molecules in inflammatory disorders and cancers. Notably, HMGB1 is a potential therapeutic target and novel biomarker in related diseases. However, the diagnostic value of HMGB1 for benign and malignant asbestos-related diseases (ARDs) remains unclear. In this work, we detected preoperative serum HMGB1 levels in Chinese asbestos-exposed (AE) and ARDs populations and further evaluated the diagnostic value of HMGB1 in patients with certain types of ARDs, including those with pleural plaques, asbestosis, or malignant mesothelioma (MM). The experimental data presented that the serum level of HMGB1 was significantly elevated in AE and ARDs subjects. Our findings indicated that serum HMGB1 is a sensitive and specific biomarker for discriminating asbestosis- and MM-affected individuals from healthy or AE individuals. In addition, serum matrix metalloproteinases 2 and 9 are not correlated with HMGB1 in ARDs. Thus, our study provides supporting evidence for HMGB1 as a potential biomarker either for the clinical diagnosis of high-risk AE cohorts or for evaluating ARDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2017/5756102

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 HMGB1 levels in serum from individuals with pleural plaques (PP), asbestosis, and MPM, exposed to asbestos and healthy controls. ELISAs shown were performed in parallel and blindly. Bars show the median of HMGB1 levels. Statistical significance was defined as two-sided ∗∗p < 0.01.
Figure 1 HMGB1 levels in serum from individuals with pleural plaques (PP), asbestosis, and MPM, exposed to asbestos and healthy controls. ELISAs shown were performed in parallel and blindly. Bars show the median of HMGB1 levels. Statistical significance was defined as two-sided ∗∗p < 0.01.CC BY · PubMed Central
Figure 2 ROC curves of HMGB1 for distinguishing patients with asbestos-related diseases (ADRs) from AE individuals or healthy controls. Four ROCs with high AUC (>0.800) were selected and shown in panels (a), (b), (c), and (d). ROC: receive operation curve; AE: asbestos-exposed; AUC: area under the curve; vs.: versus; Y: years. See details in text.
Figure 2 ROC curves of HMGB1 for distinguishing patients with asbestos-related diseases (ADRs) from AE individuals or healthy controls. Four ROCs with high AUC (>0.800) were selected and shown in panels (a), (b), (c), and (d). ROC: receive operation curve; AE: asbestos-exposed; AUC: area under the curve; vs.: versus; Y: years. See details in text.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 54

Metadata

Authors
Ying, S., Jiang, Z., He, X., Yu, M., Chen, R., Chen, J., Ru, G., Chen, Y., Chen, W., Zhu, L., Li, T., Zhang, Y., Guo, X., Yin, X., Zhang, X., & Lou, J.
Affiliations
  • Zhejiang Academy of Medical Sciences (CN)
  • Zhejiang Provincial People's Hospital (CN)
  • Jiading District Center for Disease Control and Prevention, Shanghai 201800, China
Corresponding author
Lou, Jianlin
Venue
Disease Markers
Publisher
Wiley
Published
2017
Volume
2017
Pages
1-9
ISSN
  • 0278-0240 (ISSN-L)
  • 1875-8630
OpenAlex
W2593453675
Cited by
54
References
48
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 6 · 2017: 3
FWCI
6.11
Type
journal article
Language
en
Open access
Locations
  • Disease Markers (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Natural Science Foundation of Zhejiang Province (LY16H240001, QJD1602027, 81502794, 2015KYA058, 2016KYB068, 2017PY015, 11-ZC02, 2014C03030)
  • Qianjiang Talents Project of Zhejiang Province (LY16H240001, QJD1602027, 81502794, 2015KYA058, 2016KYB068, 2017PY015, 11-ZC02, 2014C03030)
  • National Natural Science Foundation of China (LY16H240001, QJD1602027, 81502794, 2015KYA058, 2016KYB068, 2017PY015, 11-ZC02, 2014C03030)
  • Health and Family Planning Commission of Zhejiang Province (LY16H240001, QJD1602027, 81502794, 2015KYA058, 2016KYB068, 2017PY015, 11-ZC02, 2014C03030)
  • Zhejiang Committee of Science and Technology (LY16H240001, QJD1602027, 81502794, 2015KYA058, 2016KYB068, 2017PY015, 11-ZC02, 2014C03030)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Keywords
HMGB1, asbestos-related diseases, serum biomarkers, asbestos exposure, asbestosis, malignant mesothelioma, pleural plaques, MMP-2, MMP-9, diagnostic value, inflammation
MeSH terms
Mesothelioma, Malignant, Aged, Asbestosis, Female, Humans, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Biomarkers, Tumor, Case-Control Studies, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, HMGB1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. https://app.cochat.ai/papers/10.1155/2017/5756102
The paper
Ying, S., Jiang, Z., He, X., Yu, M., Chen, R., Chen, J., Ru, G., Chen, Y., Chen, W., Zhu, L., Li, T., Zhang, Y., Guo, X., Yin, X., Zhang, X., & Lou, J. (2017). Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. Disease Markers. https://doi.org/10.1155/2017/5756102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.